Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00224003
Status:
COMPLETED
Last Update Posted:
2009-09-28
First Post:
2005-09-13
Brief Title:
Study of the Safety and Efficacy of Ferrlecit Maintenance Dosing in Pediatric Hemodialysis Patients
Sponsor:
Watson Pharmaceuticals
Organization:
Watson Pharmaceuticals
Organization Data
Organization:
Watson Pharmaceuticals
Class:
INDUSTRY
Study ID:
FRO2001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Watson Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Gary Hoel RPh PhD Executive Director Clinical Research
Old Organization:
Watson Laboratory Inc